Archive · 27 Oct 2025
Semaglutide's Heart Benefits May Extend Beyond Weight Loss
Scientists have been studying a medicine called semaglutide, originally made for weight loss.
They found it can help protect your heart in ways that have nothing to do with weight loss.
The study looked at people who had obesity but didn't have diabetes.
Surprisingly, even if people didn't lose weight or lost very little, semaglutide still helped their hearts.
The researchers think the drug might be working by other methods.
It is thought to improve things like blood vessels and reducing inflammation.
They suggest it could be a medicine that changes how diseases affect the body, rather than just treating symptoms.
This could change how doctors prescribe it, helping even people who don't need to lose weight.
Semaglutide may protect the heart beyond weight loss.
Study included over 17,600 participants with obesity, but without diabetes.
Risk reduction was not directly linked to weight lost by participants.
Waist circumference reduction correlated with a reduction in cardiovascular events.
Researchers suggest semaglutide could be a disease-modifying drug.
- Who
- Researchers
- What
- Study found semaglutide protects heart health beyond weight loss.
- When
- Recently published in The Lancet
- Where
- Study involved 41 countries.
- Why
- To understand semaglutide's impact on heart health.
Potential Benefits
Limitations of Study
Prescription Guidelines
Potential Benefits
Semaglutide could benefit individuals with lower BMIs.
Limitations of Study
Study population was predominantly white and male; findings might not apply to all.
- Drug Name
- Semaglutide
- Study Focus
- Cardiovascular protection
- Study Population
- Over 17,600 patients with obesity, no diabetes
- Key Finding
- Heart protection independent of weight loss
- Waist Circumference Impact
- 33% reduction in cardiovascular events
- Researcher's Suggestion
- Consider Semaglutide a disease-modifying drug